glp 1 2 3 GLP-1 Receptor Agonists as Treatments for Type Diabetes GLP-1 vs GLP-2 vs GLP-3:

In non-diabetic mice, GLP-1 infusion increased GFR by reducing preglomerular resistance [20], an observation that could potentially explain the physiological increase in GFR observed in the postprandial compared to the fasting state, although human studies infusing GLP-1 peptide could not replicate this observation [21]

Ethics declarations Conflict of interest The authors declare no competing interests

Coskun T, Sloop KW, Loghin C et al (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept

Everyone thinks its Ozempic its not

Early promise The GLP-1 hormone is part of the intricate mechanism in our bodies to distribute glucose, but avoid the toxicity associated with high concentrations in the bloodstream